Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10406161 | SHANDONG LUYE | Risperidone sustained release microsphere composition |
Apr, 2032
(8 years from now) | |
US10098882 | SHANDONG LUYE | Risperidone sustained release microsphere composition |
Apr, 2032
(8 years from now) | |
US9532991 | SHANDONG LUYE | Risperidone sustained release microsphere composition |
Apr, 2032
(8 years from now) | |
US9446135 | SHANDONG LUYE | Risperidone sustained release microsphere composition |
Apr, 2032
(8 years from now) | |
US11110094 | SHANDONG LUYE | Risperidone sustained release microsphere composition |
Apr, 2032
(8 years from now) |
Drugs and Companies using RISPERIDONE ingredient
Market Authorisation Date: 13 January, 2023
Treatment: Treatment of schizophrenia in adults
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR